An oral ghost delivery device for macromolecules

Abstract

Recently, there has been an explosion of interest in developing biopharmaceutical therapeutics for the treatment of life altering conditions. The main issue with the utilization of biopharmaceutical therapeutics is the mode of administration. The Oral Ghost Drug Delivery (OGDD) device could potentially enable the administration of these peptide therapeutics via the oral route and significantly extend the application of these advanced therapeutic compounds.